In light of the strong support for the involvement of COX2 in prostate carcinogenesis coupled with the initial evidence that inherited differences in COX2 may impact risk of disease, we evaluated the association between common genetic variation in COX2 and prostate cancer risk in a case–control study of advanced prostate cancers. Here, PTGS2 is linked to Familial prostate cancer.